Results 251 to 260 of about 410,300 (316)

Current clinical research status and future treatment directions for liver cirrhosis combined with portal vein thrombosis. [PDF]

World J Hepatol
He WL, Yan S, Lu JJ, Chen L, Wu JZ.
europepmc   +1 more source

Diagnostic significance of matrix metalloproteinases in predicting one-year mortality in liver cirrhosis

Alexandr Yagoda, Pavel Koroy, Temirlan Ruslanovich Dudov   +2 more
openalex   +1 more source

A juvenile female case of liver cirrhosis found by the chance of an oral administration of turmeric

, 2006
Taira Zenitani, M. Takagi, Takashi Araki, Masashi Takamatsu, Kenji Suzuki, Yoko Kasuga, Yoshihiko Naito, M Niiya, Kiyotaka Fujise, Shiro Maeyama   +9 more
openalex   +2 more sources

Mortality from cancer and non‐cancer diseases in the Lithuanian cohort of Chernobyl cleanup workers (2001–2020)

International Journal of Cancer, EarlyView.
What's New? Following the Chernobyl disaster, workers were recruited from formerly Soviet‐occupied areas, including Lithuania, to participate in clean‐up efforts. Radiation exposure incurred by workers during these efforts offers a unique opportunity for the study of long‐term health effects.
Rita Steponaviciene, Ausrele Kesminiene, Auguste Kaceniene, Giedre Smailyte   +3 more
wiley   +1 more source

Felty syndrome with liver cirrhosis: A case report. [PDF]

Medicine (Baltimore)
Wan C, Wu M, Jiang L, Zhang C, Gan G, Sun X.   +5 more
europepmc   +1 more source

Pre‐diagnostic immunological markers of bacterial translocation and liver cancer risk: A nested case–control analysis of 12 prospective cohorts

International Journal of Cancer, EarlyView.
What's New? Disruption of the gut–liver axis has been suggested to play an important role in liver carcinogenesis. However, limited prospective research has explored associations between potentially harmful gut‐derived bacterial products and liver cancer risk.
Cody Z. Watling, Peter T. Campbell, Barry I. Graubard, Yanyu Wang, Andrew T. Gewirtz, Xuehong Zhang, Matthew J. Barnett, Julie E. Buring, Yu Chen, A. Heather Eliassen, J. Michael Gaziano, Jonathan N. Hofmann, Wen‐Yi Huang, Jae H. Kang, Jill Koshiol, Erikka Loftfield, I‐Min Lee, Steven C. Moore, Lorelei A. Mucci, Marian L. Neuhouser, Christina C. Newton, Mark P. Purdue, Howard D. Sesso, Martha Shrubsole, Rashmi Sinha, Lesley Tinker, Matthew Triplette, Caroline Y. Um, Kala Visvanathan, Eleanor L. Watts, Jean Wactawski‐Wende, Walter Willett, Fen Wu, Wei Zheng, Dinesh Barupal, Jessica L. Petrick, Katherine A. McGlynn   +36 more
wiley   +1 more source

A Case of a Young Pregnant Patient With Congenital Portal Vein Stenosis, Portal Hypertension, and Liver Cirrhosis. [PDF]

Cureus
Alzain FA, Alolaian RJ, Alolayan AJ, Alolaian AJ, Albadrani YH.   +4 more
europepmc   +1 more source

Combination of heterozygous APOB gene mutation with PNPLA3 and TM6SF2 variants promotes steatotic liver disease, cirrhosis and HCC development [PDF]

Yasmina Chouik, Mathilde Di Filippo, Sylvie Radenne, Jérôme Dumortier, Philippe Moulin, Massimo Levrero   +5 more
openalex   +1 more source

Saliva as a TDM matrix and its application in the model‐informed precision dosing

The Journal of Clinical Pharmacology, EarlyView.
Abstract This study reviews the main points of saliva as a therapeutic drug monitoring (TDM) matrix, its advantages and limitations, the methods of saliva sample collection and testing, the types of drugs in saliva TDM, and the methods of establishing saliva population pharmacokinetic (Pop PK) models, as well as summarizes the experiences and ...
Baohua Xu, Yujie Wen, Jinxia Lu, Maobai Liu, Xin Luo, Wei Huang, Helin Xie, Yu Cheng, Hongqiang Qiu, Xuemei Wu   +9 more
wiley   +1 more source

Spontaneous Refractory Intercostal Artery Hemorrhage in a Patient With Decompensated Liver Cirrhosis. [PDF]

Cureus
Kimura J, Chauhan P, Eriksen C, Cooper M, Prasad R.   +4 more
europepmc   +1 more source